| dc.contributor.author | Ronald F van Vollenhoven | |
| dc.contributor.author | Laurent Arnaud | |
| dc.contributor.author | Marta Mosca | |
| dc.contributor.author | Nathalie Costedoat-Chalumeau | |
| dc.contributor.author | Elisabet Svenungsson | |
| dc.contributor.author | Daniel J Wallace | |
| dc.contributor.author | Judith A James | |
| dc.contributor.author | Kenneth Kalunian | |
| dc.contributor.author | Susan Manzi | |
| dc.contributor.author | Michelle A Petri | |
| dc.contributor.author | Jill Buyon | |
| dc.contributor.author | Rosalind Ramsey-Goldman | |
| dc.contributor.author | Ian N Bruce | |
| dc.contributor.author | Guillermo Ruiz-Irastorza | |
| dc.contributor.author | Ellen M Ginzler | |
| dc.contributor.author | Manuel Francisco Ugarte-Gil | |
| dc.contributor.author | Bernardo A Pons-Estel | |
| dc.contributor.author | Juanita Romero-Diaz | |
| dc.contributor.author | Sang-Cheol Bae | |
| dc.contributor.author | Anisur Rahman | |
| dc.contributor.author | Paul R Fortin | |
| dc.contributor.author | Dafna D Gladman | |
| dc.contributor.author | Andreas Jönsen | |
| dc.contributor.author | Murat Inanc | |
| dc.contributor.author | Diane L Kamen | |
| dc.contributor.author | Søren Jacobsen | |
| dc.contributor.author | Jorge Sanchez-Guerrero | |
| dc.contributor.author | Évelyne Vinet | |
| dc.contributor.author | Murray Urowitz | |
| dc.contributor.author | David Isenberg | |
| dc.contributor.author | Sasha Bernatsky | |
| dc.contributor.author | John Reynolds | |
| dc.contributor.author | Eric Morand | |
| dc.contributor.author | Vernon Farewell | |
| dc.contributor.author | Claudia Elera-Fitzcarrald | |
| dc.contributor.author | Cristina Reátegui-Sokolova | |
| dc.contributor.author | Alexandre Voskuyl | |
| dc.contributor.author | Anca D Askanase | |
| dc.contributor.author | John Hanly | |
| dc.contributor.author | Anselm Mak | |
| dc.contributor.author | Sung Sam Lim | |
| dc.contributor.author | Christine Peschken | |
| dc.contributor.author | Graciela S. Alarcon | |
| dc.contributor.author | Joanna Leong | |
| dc.contributor.author | Bhushan Dharmadhikari | |
| dc.contributor.author | Nien Yee Kow | |
| dc.contributor.author | Cinthia Aranow | |
| dc.contributor.author | Mary Ann Dooley | |
| dc.contributor.author | Mike Cheung | |
| dc.contributor.other | Department of Rheumatology and Clinical Immunology, Amsterdam University Medical Center, Amsterdam, The Netherlands | |
| dc.contributor.other | 1 Service de rhumatologie, Hôpitaux Universitaires de Strasbourg, Laboratoire d`Immuno Rhumatologie Moléculaire, INSERM UMR_S1109, Strasbourg, France | |
| dc.contributor.other | 1 Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy | |
| dc.contributor.other | Cochin Hospital, Paris, France | |
| dc.contributor.other | Karolinska Institutet, Karolinska University Hospital, Rheumatology Unit, Department of Medicine, Solna, Stockholm, Sweden | |
| dc.contributor.other | Rheumatology, Cedars-Sinai Medical Center, West Hollywood, California, USA | |
| dc.contributor.other | Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA | |
| dc.contributor.other | 9University of California, San Diego, La Jolla, United States of America | |
| dc.contributor.other | Allegheny Health Network, Pittsburgh, Pennsylvania, USA | |
| dc.contributor.other | Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA | |
| dc.contributor.other | Rheumatology, NYU Langone Health, New York City, New York, USA | |
| dc.contributor.other | Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA | |
| dc.contributor.other | Kellgren Centre for Rheumatology, Manchester University Hospitals NHS Trust, Manchester, UK | |
| dc.contributor.other | Autoimmune Diseases Research Unit, Department of Internal Medicine, BioCruces Health Research Institute, Hospital Universitario Cruces, University of the Basque Country, Barakaldo, Spain | |
| dc.contributor.other | Medicine, SUNY Downstate Medical Center, New York City, New York, USA | |
| dc.contributor.other | Grupo Peruano de Estudio de Enfermedades Autoinmunes Sistémicas, Universidad Cientifica del Sur, Lima, Peru | |
| dc.contributor.other | 5Rheumatology, Grupo Oroño – Centro Regional de Enfermedades Autoinmunes y Reumáticas (GO-CREAR), Rosario, Argentina | |
| dc.contributor.other | Immunology and Rheumatology, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Ciudad de Mexico, Mexico | |
| dc.contributor.other | 28 Hanyang University Hospital for Rheumatic Diseases, Seoul, Korea (the Republic of) | |
| dc.contributor.other | Maternal and Child Health Division, International Centre for Diarrhoeal Disease Research Bangladesh, Dhaka, Dhaka District, Bangladesh | |
| dc.contributor.other | Division of Rheumatology, CHU de Québec, Universite Laval, Quebec City, Quebec, Canada | |
| dc.contributor.other | Krembil-Gladman Psoriatic Arthritis Research Program, Centre for Prognosis Studies in the Rheumatic Diseases, Schroeder Arthritis Institute, Krembil Research Institute, University Health Network, Toronto, Ontario, Canada | |
| dc.contributor.other | Department of Rheumatology, Lund University Department of Clinical Sciences Lund, Lund, Sweden | |
| dc.contributor.other | Division of Rheumatology, Department of Internal Medicine, Istanbul Medical Faculty, Istanbul University, Fatih, Turkey | |
| dc.contributor.other | Medical University of South Carolina, Charleston, South Carolina, USA | |
| dc.contributor.other | Department of Rheumatology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark | |
| dc.contributor.other | Mount Sinai Hospital and University Health Network, Toronto, Ontario, Canada | |
| dc.contributor.other | McGill University, Divisions of Rheumatology and Clinical Epidemiology, Montreal, Canada | |
| dc.contributor.other | Schroeder Arthritis Institute, Krembil Research Institute, University Health Network, Toronto, Ontario, Canada | |
| dc.contributor.other | Centre for Rheumatology, Department of Medicine, University College London, London, UK | |
| dc.contributor.other | Divisions of Rheumatology and Clinical Epidemiology, McGill University Health Centre, Montreal, Quebec, Canada | |
| dc.contributor.other | 1 Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia | |
| dc.contributor.other | 1Department of Medicine, School of Clinical Sciences at MH, Monash University, Australia, Australia | |
| dc.contributor.other | 1Queen Elizabeth II Health Sciences Center and Dalhousie University, Rheumatology/Medicine, Halifax, Nova Scotia, Canada | |
| dc.contributor.other | Hospital Nacional Guillermo Almenara Irigoyen, Reumatologia, Lima, Peru | |
| dc.contributor.other | Rheumatology Department, Hospital Nacional Guillermo Almenara Irigoyen, EsSaalud, Lima, Peru | |
| dc.contributor.other | VUmc, Rheumatology, Amsterdam, Netherlands | |
| dc.contributor.other | Department of Medicine, Columbia University Irving Medical Center, New York, New York, USA | |
| dc.contributor.other | 1Queen Elizabeth II Health Sciences Center and Dalhousie University, Rheumatology/Medicine, Halifax, Nova Scotia, Canada | |
| dc.contributor.other | Division of Rheumatology, Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore | |
| dc.contributor.other | 3Department of Medicine, Division of Rheumatology, Emory University School of Medicine, USA | |
| dc.contributor.other | University of Manitoba, Winnipeg, Manitoba, Canada | |
| dc.contributor.other | The University of Alabama, Birmingham, USA, School of Medicine, Birmingham, United States of America | |
| dc.contributor.other | Department of Medicine, Changi General Hospital, Singapore | |
| dc.contributor.other | Department of Physiology, National University of Singapore, Singapore, Singapore | |
| dc.contributor.other | Yong Loo Lin School of Medicine, National University of Singapore, Singapore | |
| dc.contributor.other | Feinstein Institute for Medical Research, Manhasset, New York, USA | |
| dc.contributor.other | Thurston Arthritis Research Centre, University of North Carolina System, Chapel Hill, North Carolina, USA | |
| dc.contributor.other | Department of Psychology, Faculty of Arts and Social Sciences, National University of Singapore, Singapore | |
| dc.date.accessioned | 2025-10-09T05:21:29Z | |
| dc.date.available | 2025-10-09T05:21:29Z | |
| dc.date.issued | 01-May-2021 | |
| dc.identifier.uri | https://lupus.bmj.com/content/8/1/e000590.full | |
| dc.identifier.uri | http://digilib.fisipol.ugm.ac.id/repo/handle/15717717/40976 | |
| dc.description.abstract | Objective In systemic lupus erythematosus (SLE), disease activity and glucocorticoid (GC) exposure are known to contribute to irreversible organ damage. We aimed to examine the association between GC exposure and organ damage occurrence.Methods We conducted a literature search (PubMed (Medline), Embase and Cochrane January 1966–October 2021). We identified original longitudinal observational studies reporting GC exposure as the proportion of users and/or GC use with dose information as well as the occurrence of new major organ damage as defined in the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index. Meta-regression analyses were performed. Reviews, case-reports and studies with <5 years of follow-up, <50 patients, different outcomes and special populations were excluded.Results We selected 49 articles including 16 224 patients, 14 755 (90.9%) female with a mean age and disease duration of 35.1 years and of 37.1 months. The mean follow-up time was 104.9 months. For individual damage items, the average daily GC dose was associated with the occurrence of overall cardiovascular events and with osteoporosis with fractures. A higher average cumulative dose adjusted (or not)/number of follow-up years and a higher proportion of patients on GC were associated with the occurrence of osteonecrosis.Conclusions We confirm associations of GC use with three specific damage items. In treating patients with SLE, our aim should be to maximise the efficacy of GC and to minimise their harms. | |
| dc.language.iso | EN | |
| dc.publisher | BMJ Publishing Group | |
| dc.subject.lcc | Immunologic diseases. Allergy | |
| dc.title | Impact of glucocorticoids on the incidence of lupus-related major organ damage: a systematic literature review and meta-regression analysis of longitudinal observational studies | |
| dc.type | Article | |
| dc.description.doi | 10.1136/lupus-2021-000590 | |
| dc.title.journal | Lupus Science and Medicine | |
| dc.identifier.e-issn | 2053-8790 | |
| dc.identifier.oai | oai:doaj.org/journal:d0efe4f35013426eb5c96e31ad0e293f | |
| dc.journal.info | Volume 8, Issue 1 | |